Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Home

Header Top Menu

  • News & Featured Stories
  • Media
  • Careers
  • Contact Us
  • Our Science

    Sub Menu 1

    • Pfizer in the UK
      • Our History
      • Pharmaceutical Sciences
      • Devices Centre of Excellence
      • Global Regulatory Affairs
      • Material Characterisation Team
      • Anti-Counterfeit Laboratory
    • Our Therapy Areas
      • Anti-Infectives
      • Inflammation and Immunology
      • Internal Medicine
      • Oncology
      • Rare Disease
      • Vaccines

    Sub Menu 2

    • Developing New Medicines
      • Clinical Trials
      • Pipeline
    • Research partnerships
      • ADDoPT
      • Innovative Target Exploration Network (ITEN)
      • INSPIRE Programme
      • Medical Research Council Collaboration
      • The Stratified Medicine Programme
      • Partnership with Regeneron for UK Biobank exome sequencing
    • Breakthroughs that change patients’ lives
    Hot Topic

    Re-shaping Cancer

    Re-shaping cancer
  • Products

    Sub Menu 4

    • Prescription medicines

    Sub Menu 5

    • Safety of Medicines
      • Medicines Regulation
      • Reporting Side Effects
      • Counterfeit Medicines
    Hot Topic

    Vaccines partnerships

    Vaccines partnerships
  • Responsibility

    Sub Menu 7

    • Transparency
      • HCP & HCO Annual Disclosure Reports
      • Healthcare Organisation Grants
      • Research and Development Funding
      • Patient Organisation Funding and Support
    • Codes of Conduct
      • Gender Pay Gap Report
      • Section 172 Statements
      • Pfizer UK Modern Slavery Statement
      • Pfizer UK Tax Strategy

    Sub Menu 8

    • Environmental Sustainability
      • Climate Action
      • Global Actions
      • Our Partnerships & Commitments
      • Sustainable Medicines
      • UK Actions
    • Insurance Details
    • Animal Welfare
    Hot Topic

    Putting Patients First

    Putting Patients First
  • UK Society

    Sub Menu 10

    • Social Investment
      • Volunteering and Fundraising
      • Medicines Donations
    • Raising Public Awareness
      • Change the Course
      • Pfizer Sponsors Science Museum Group's 'Cancer Revolution' Exhibition
      • Pfizer Sponsors the Superhero Series
      • Pfizer sponsors Science Museum exhibition 'Superbugs'
      • Pfizer at the British Science Festival
      • Turning Heads at Westminster

    Sub Menu 11

    • Science Education
      • Developing Science Talent
      • 'Superbugs Join The Fight' School Programme
      • Online Learning
        • Student Education Area
        • Teacher Resources
      • Community Lab
      • Career Talks
      • Lab in a Box
    • Pfizer Worldwide
      • Global Health Fellows
      • Global Aid and Emergency Relief
      • International Trachoma Initiative
    Hot Topic

    'Superbugs' Competition Winners

    Superbugs Winners
  • UK Health System

    Sub Menu 16

    • Working with the NHS and other Healthcare Organisations
      • Collaborative Working
        • Collaborative Working Project between Lloyds Pharmacy and Pfizer Vaccines
        • Joint Working
      • Donations and Grants
        • Independent Medical Grants and Donations
        • Donations of Goods, Services and Benefit in Kind
        • Grants
        • Donations and Grants Enquiry Form
    • Working with Healthcare Professionals
      • FAQs: Working with Healthcare Professionals
      • Pharmacy
      • Healthcare Professionals Congress Sponsorship

    Sub Menu 17

    • Working with Patient Organisations
      • Patient Involvement in Research and Development
      • Our ongoing partnership with the UK Sepsis Trust
      • Partnering with the NIHR and young people on clinical research
    • Pfizer Healthcare Hub
      • Pfizer Healthcare Hub: 2018
      • Pfizer Healthcare Hub: 2017
      • Connect with the Hub
    Hot topic

    Osteoarthritis

    Osteoarthritis
  • News & Featured Stories
  • Media
  • Careers

    Carrers

    • Search Current Vacancies
    • Apprenticeships
      • Apprenticeship Vacancies
    • Undergraduate Placements
      • Undergraduate Vacancies
    • Meet our people
    • UK Top Employer
    • How Pfizer is fostering meaningful growth for every colleague, everywhere
  • Contact Us
  • Footer links

    Footer mobile menu

    • Footer Menu
    • Footer menu
      • Contact Us
      • Cookie Policy
      • Terms of Use
      • Privacy Policy
      • Sitemap
    • Footer social item
      • Facebook
      • Twitter
      • Instagram
      • YouTube

2021: Stronger and Smarter

2021: Stronger and Smarter
News & Featured Stories/ 2021: Stronger and Smarter
21/01/2021

Ben Osborn
Country Manager, Pfizer UK

As we enter 2021, I have been thinking over the ups and downs of an extraordinary year passed.

 

Whilst we have seen a number of vaccines authorised for usage by the Medicines and Healthcare Products Regulatory Agency, which has really demonstrated the value of science, the pandemic continues to have a profound impact on everyone in the UK.

We all had to learn to live through an ever-changing situation and I have particular sympathy for older people and those with long-term conditions, who have had to cope with indefinite uncertainty regarding their health. The latest figures on the number of people waiting over a year for hospital treatment in England make sobering reading, having reached their highest levels since 2008.1 Many people waiting for routine elective operations, like hip or knee replacements for example, will be living with severe pain and loss of mobility while they wait.2

While searching for any silver linings within such prolonged disruption, I do feel hopeful that our devoted and resourceful NHS professionals are working hard to retain the best of the beneficial changes and innovations they implemented under the challenging circumstances of repeated lockdowns. Examples of this include physiotherapy telehealth models3 and the digital solutions that could enable more efficient organisation of test results and medication details and improved access to information.4 Crucially, the virtual healthcare many of us have embraced through necessity could also offer opportunities for improved efficiency, convenience and outcomes.

Our population is ageing, so prioritising appropriate interventions and support for people now to age healthily and retain their independence could reduce demand for more expensive health or social care later on." 

Given the devastating impact of the pandemic,5 particularly among older people and those with underlying conditions,6 I’m increasingly convinced that we need to develop a new mindset regarding the future of health. Our population is ageing,7 so prioritising appropriate interventions and support for people now to age healthily and retain their independence could reduce demand for more expensive health or social care later on.

The NHS has set out to deliver better health for the whole population, improved quality care for all patients and financially sustainable services for the taxpayer.8 The opportunity presented by the creation of Integrated Care Systems is significant and will be critical for enabling more place-based care, focused on meeting the needs of local populations. The vision for integrated care could be truly transformational for older people and for people living with one or many long-term chronic conditions; by aligning systems around people means better access to simple, joined-up care and treatment when it's needed and access to preventative services and proactive support to keep well.

The vision for integrated care could be truly transformational for older people and for people living with one or many long-term chronic conditions." 

It’s certainly a timely aspiration as 2020 marked the start of the World Health Organization’s Decade of Healthy Ageing with a key priority of aligning health systems to the needs of older people.9 The accompanying global data portal will bring visibility to the health and well-being of older people and ultimately drive action for national policies and plans to support healthy ageing.10 At Pfizer, we see good health as fundamental to the social and economic potential of the UK, and I believe it’s time to value and invest in health as a ‘national asset’ rather than a cost to be borne.

In spite of the pandemic continuing to separate many of us from loved ones, and with much of our mental reserves of resilience depleted, I am drawing strength and inspiration from the determination and amazing ideas I hear every day from UK colleagues and collaborators. We are now striving to build back our systems and communities in a way that is stronger, smarter and more equitable after the pandemic. I also, of course, take heart in knowing that #ScienceWillWin as indicated by the many innovative partnerships across biopharma and academia that are advancing coronavirus vaccines and medicines. I can think of few things that make me more optimistic about what this year will bring.

 

References

  1. BBC News. Coronavirus: Year-long waits for hospital care in England worst since 2008 Nov 2020.
  2. The Telegraph. Covid's 'collateral damage': how delayed operations have created a health timebomb Oct 2020.
  3. Physiotherapy. “Physio Anywhere”: digitally-enhanced outpatient care as a legacy of coronavirus 2020 July 2020.
  4. Pfizer UK. ByYourSide app and website launched to help cancer patients in need June 2020.
  5. WHO. Impact of COVID-19 on people’s livelihoods, their health and our food systems Oct 2020.
  6. Nature. The coronavirus is most deadly if you are older and male — new data reveal the risks Aug 2020.
  7. Office for National Statistics. Living longer: how our population is changing and why it matters Aug 2018.
  8. NHS. NHS Long Term Plan Jan 2019.
  9. WHO. Decade of Healthy Ageing Aug 2020.
  10. WHO. WHO launches portal for global data on the health and well-being of older people Oct 2020.

 

PP-PFE-GBR-4214 / November 2021

Related Hot Topics
AMR Reimbursement Pilot Launch
World First Cross-Industry Initiative Launches in the Continued Fight Against…
What is a Variant
What is a Variant?
COVID-19 Vaccine Equity
Working To Reach Everyone, Everywhere
VacciNation report
VacciNation: tackling health inequalities across England
Patients at heart of clinical trials
Why putting patients at the heart of Pfizer UK’s clinical trials continues to…
Infection Management Coalition Paper
Cross-Industry Coalition Tackling ‘Hidden Pandemic’ of Antibiotic Resistant…
Blueprint for gene therapy adoption
Pfizer UK launch blueprint for the UK adoption of cell and gene therapies
Inhealthcare
Inhealthcare: where are they now?
Tags
COVID-19
UK Health System
Internal Medicine

Footer

  • Contact Us
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Sitemap

Footer aside

  • Footer Aside
    • Facebook
    • Twitter
    • Instagram
    • YouTube

Copyright © 2017-2022 Pfizer Limited. PP-PFE-GBR-4248 / Nov 2021. All rights reserved. Registered in England and Wales No. 526209. Registered office: Ramsgate Road, Sandwich, Kent CT13 9NJ. VAT No. GB201048427